P.016 A comparative analysis of kidney transplantation outcomes in systemic lupus erythematosus patients with disease flare vs. non-flare groups
Dr. Jin-Myung Kim, Korea
P.017 Comparison of ABO-incompatible kidney transplant outcomes between robot-assisted and open techniques
Dr. Jin-Myung Kim, Korea
P.018 Subclinical graft rejection and lower TTV viral load in renal transplant patients
Carlos H. Diaz, Argentina
P.020 MHC class I chain related molecule A (MICA) antibodies are highly prevalent in patients attending Inkosi Albert Luthuli Central Hospital, Durban, South Africa
Alain Assounga, South Africa
P.022 Elevated Circulating Cell Free DNA in Lung Transplant: Beyond Infection and Rejection
Dr. Alonso J Marquez, United States
P.023 Comparative outcomes of simultaneous versus staged nephrectomy in polycystic kidney disease patients undergoing kidney transplantation
Mr. Pedro H. Oliveira Sr., Brazil
P.024 Impact of diabetic donor kidneys on long-term outcomes in kidney transplant recipients: a propensity score matching analysis
Mr. Pedro H. Oliveira Sr., Brazil
P.025 Is a complete viral load suppression required to reduce the risk of cytomegalovirus recurrence in kidney transplant recipients using the preemptive strategy?
Mr. Pedro H. Oliveira Sr., Brazil
P.026 Longitudinal SARS-CoV-2 antibody and T-cell immune responses in vaccinated kidney transplant recipients and patients on dialysis
Monica Rika Nakamura, Brazil
P.027 Utilisation of livers donated after circulatory death (DCD) for transplantation – a large cohort study evaluating pre-retrieval biochemical characteristics and transplant outcomes
Dr. Syed Hussain Abbas, United Kingdom
P.028 Optimisation of donation after circulatory death livers – removal of extracellular histones during normothermic perfusion and following whole blood reperfusion in an ex-situ porcine model
Dr. Syed Hussain Abbas, United Kingdom
P.029 Immunological insight into IgA nephropathy: Dissecting immune cell responses and transcriptomic profiles for targeted therapeutic strategies
Miss Merve Bilici, United Kingdom
P.030 Evaluation of relationship between CD68-positive macrophages and clinical and laboratory parameters in kidney transplant recipients who experienced transplant kidney biopsy
Dr. Burak Sayin, Turkey
P.031 Unveiling the molecular symphony: Exploring miR-142-5p and miR-192-1's ınfluence on renal transplant rejection and fibrosis
Dr. Begum Yavascaoglu Uney, Turkey
P.034 Diagnosis and classification of kidney transplant rejection via surface-enhanced raman spectroscopy combined with machine learning techniques from a single drop of serum
Dr. Jin-Myung Kim, Korea
P.035 Longitudinal change patterns in estimated glomerular filtration rate in a European population of living kidney donors
Dr. Manuela B Almeida, Portugal
P.036 Comparative profiles of circulating T-cell subsets and cytokines in Kidney allograft recipients with inflammatory interstitial fibrosis and tubular atrophy and Chronic antibody-mediated rejection
Prof. Narayan Prasad, India
P.038 Joint modeling of longitudinal renal function and graft survival data in kidney transplantation
Dr. Semiha Özgül, Turkey
P.041 Switching from Ciclosporin to Tacrolimus as De Novo Calcineurin Inhibitor in Lung Transplantation: First Results of a Multidisciplinary Quality Assurance Project
Dr. Mace Matthew Schuurmans, Switzerland
P.042 Absolute lymphocyte count as an easy bedside tool to determine the dosage of induction agent in kidney transplant recipients
Dr. Akash Gupta, India
P.043 Enhancing prediction of post-nephrectomy renal function in living donors: Integration of ai-measured kidney volumes with machine learning models
Dr. Eun-Ah Jo, Korea
P.044 Rhabdomyolysis after cooked local fish consumption (Haff Disease) in kidney transplant in South of Brazil - Case report
Dr. Patricia D'Almeida Bianco, Brazil
P.045 Mucormycosis in post renal transplant
Dr. Navva Pavan Kumar Rao, India
P.046 Acute graft pyelonephritis in a kidney transplant recipient – a single centre experience in northern India
Dr. Shyam Bansal MD,DM, India
P.047 Renal Artery Thrombosis and Graft loss
Dr. Navva Pavan Kumar Rao, India
P.048 Probiotic intervention to reduce postoperative inflammation in liver transplantation
Dr. Judith Kahn, Austria
P.049 Urinary tract infections in kidney transplant recipients: Antimicrobial treatment choices are decreasing
Hande Arslan, Turkey
P.050 Evaluation of cytomegalovirus pneumonia in transplant recipients
Dr. Tugba Yanik Yalcin, Turkey
P.051 Comparision of invasive pulmoner aspergillosis between transplant and non-transplant patient
Dr. Tugba Yanik Yalcin, Turkey
P.052 Is celulitis always cellulitis? Unusual manifestation of cryptococcosis in solid organ transplantation: A case report
Hande Arslan, Turkey
P.053 The importance of donor blood culture in heart transplant patients: A case report
Hande Arslan, Turkey
P.054 CMV colitis in solid organ transplant patients
Dr. Gonca Ozgun, Turkey
P.055 Cytomegalovirus, aspergillus, influenza and xdr bacterial pneumoniae coinfection in kidney transplant patients: A case report
Dr. Tugba Yanik Yalcin, Turkey
P.056 High-Dose Intravenous Immunoglobulin for BK Virus DNaemia Protects Against BK Nephropathy But Not Acute Rejection
Dr. Hersharan Kaur Sran, Singapore
P.058 The role of pericyte dysfunction in antibody-mediated rejection on the prognosis of transplanted kidneys
Prof. Zijie Wang, People's Republic of China
P.059 Syk derived from M1 polarized macrophage-derived exosomes aggravates vascular endothelial injury in antibody-mediated rejection of renal transplant
Prof. Zijie Wang, People's Republic of China
P.060 Deletion of β-catenin in macrophages alleviates transplanted renal interstitial fibrosis by inhibiting pericyte-to-myofibroblast transformation
Prof. Zijie Wang, People's Republic of China
P.061 Gut microbiota composition and metabolites reflects disease severity and short-term allograft function in renal transplant recipients with COVID-19
Prof. Zijie Wang, People's Republic of China
P.062 Impacts of warm ischemia on myocardial protein phosphorylation after normothermic ex vivo reperfusion of hearts donated after circulatory death in a rat DCD model
Dr. Ling Gao, Australia
P.063 Comparison of preoperative desensitization strategies in ABO-incompatible living kidney transplantation and subsequent COVID-19 infection
Prof. Puxun Tian, People's Republic of China
P.064 Establishment and clinical application of immune risk stratification criteria for kidney transplant recipients
Prof. Puxun Tian, People's Republic of China
P.065 Evaluation of the therapeutic effects of argon inhalation in a renal transplantation model using MHC-inbred CLAWN miniature swine
Hisashi Sahara, Japan
P.066 Expression and effect of Pbrm1 in renal ischemia-reperfusion injury
Dr. Yang Gao, People's Republic of China
P.067 Gender disparity in kidney transplantation in Mongolia an analysis of the ASTREG WIT KT registry
Dr. Lkhaakhuu L Od-Erdene Od, Mongolia
P.069 Navigating Immunological Risk in Highly-Sensitized Transplant Candidates: Insights from DSA Assessment and FCXM Analysis
Dr. Gustavo Ferreira, Brazil
P.070 Immediate results of kidney transplantation from ABO-incompatible donors
Dr. Nigina B Elmuradova, Uzbekistan
P.071 Application of Hisense CAS to assess donor liver volume for living donor and split liver transplantation
Dr. Feng Wang, People's Republic of China
P.072 Synergistic renoprotective effects of green tea extract and dipeptidyl peptidase 4 inhibitor gemigliptin against tacrolimus-induced nephropathy in Mice
Prof. Byung-Chul Shin, Korea
P.074 SPK-PK : a prospective pharmacokinetics study of tacrolimus exposure in pancreas transplantation
Dr. Christophe Masset, France
P.077 Engineered mesenchymal stem cell-mediated release of the chemokine CCL28 remodels the immune microenvironment to resist graft rejection
Dr. Yanan Li, People's Republic of China
P.078 ZFP91 phase isolation mediates phenotypic and functional changes of effector T cells
Miss Di Wu, People's Republic of China
P.079 The ERTA-Ab study: Anti-endothelin-1 receptor Type A antibodies in pediatric renal transplantation
Emanuele Cozzi, Italy
P.080 Anorectal transplantation in swine. The first series with extended survival
Flávio H F Galvao, Brazil
P.081 Evidence of liver tolerance in a model of hyperacute rejection after discordant xenotransplantation.
Flávio H F Galvao, Brazil
P.082 IL-33/ST2 axis during chronic rejection after liver transplantation
Gabriel E. Gondolesi, Argentina
P.083 Biological sex modulates the effects of the immunoregulatory fibrinogen-like protein 2 molecule on alloimmunity
Ms. Christina Lam, Canada
P.085 Ischemia change HLA-G expression in peripheral blood and spleen T lymphocyte subsets
Dr. Miray Kavuzlu, Turkey
P.086 Endoplasmic reticulum stress in recipient spleen follicular B lymphocytes in transplantation may affect the alloimmune response of T lymphocytes
Dr. Miray Kavuzlu, Turkey
P.087 Cytotoxicity of FK506 through TRAIL, Fas and TLR4 signaling pathway in human jurkat T Cell4
Prof. Soo Jin Na Choi, Korea
P.089 Novel method of immune monitoring based on alloreactive T cells
Dr. Ryosuke Arata, Japan
P.090 The effect of hemolysis during normothermic machine perfusion of the kidney in RPTEC cells